Adhera Therapeutics Inc 's

• ATRX's Stock Performance relative to its Competitors

Contineum Therapeutics Inc Share Performance +3.58% 30 Days

Contineum Therapeutics Inc Profile The company develops drug candidates focused on neuroscience, inflammation, and immunology diseases. More about Contineum Therapeutics Inc 's Market Share

Opus Genetics Inc Share Performance +0.96% 30 Days

Opus Genetics Inc Profile Opus Genetics develops gene therapies for inherited retinal diseases and other ophthalmic disorders. More about Opus Genetics Inc 's Market Share

Jazz Pharmaceuticals Plc Share Performance -2.08% 30 Days

Jazz Pharmaceuticals Plc Profile Jazz Pharmaceuticals Plc is a biopharmaceutical company focused on developing and commercializing innovative therapies for a range of medical conditions. Their business model revolves around conducting extensive research and development to identify novel molecules and compounds that can address unmet medical needs. By leveraging strategic partnerships, acquisitions, and licensing agreements, they aim to bring these therapies to market and provide valuable treatment options to patients worldwide. More about Jazz Pharmaceuticals Plc's Market Share

Kiniksa Pharmaceuticals International Plc Share Performance +6.65% 30 Days

Kiniksa Pharmaceuticals International Plc Profile Kiniksa Pharmaceuticals Ltd is a biopharmaceutical company focused on developing and commercializing therapeutics for patients with debilitating diseases and unmet medical needs. Their business model revolves around identifying potential drug candidates, conducting rigorous research and development, and ultimately bringing these drugs to market to provide innovative treatment options. They generate revenue through the sale of their products and collaborations with other companies for the development and commercialization of their therapies. More about Kiniksa Pharmaceuticals International Plc's Market Share

Karuna Therapeutics Inc Share Performance +74.20% One Year

Karuna Therapeutics Inc Profile Karuna Therapeutics Inc's business model revolves around developing innovative therapies for neuropsychiatric disorders by leveraging the potential of its proprietary platform, targeting the muscarinic cholinergic receptors in the brain. More about Karuna Therapeutics Inc 's Market Share

Sources: Adhera Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 1, 2026 7:47 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Adhera Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.